The New York Times on August 23, 2016, wrote an investigative piece about Governor Andrew Cuomo's efforts to develop a high-tech film studio in upstate New York (pictured below from the Times article), focusing in part upon the involvement of Ryan R. Johnson in the project. The article...
NetJets Inc., a Walsh client, has sued three founders of Phoenix Star Capital, a failed investment firm, seeking to collect on amounts due for private aviation services. The suit has garnered attention in Forbes. The full piece is available here. For more information about the firm’s...
Gilead Sciences Inc. and Emory University, represented by Liza M. Walsh and Eleonore Ofosu-Antwi, have accused Indian drugmaker Hetero Drugs Ltd. of infringing four patents protecting Truvada®, Gilead's commercially successful HIV treatment. Read Full Article Here ›...
Quaker Oats to Fight Syrup Claims in Cali Read Full Article Here >...
Retirement Plan Can Mandate Arbitration, Cost-Sharing. Read Full Article Here ›...
Walsh Cyber Lawyer Peter J. Pizzi, CIPP/US, explains how to find the key items of evidence in a digital morass. For more information, read the full article, or contact Peter at ppizzi@walsh.law or (973) 757-1011....
A veteran of countless federal court pharmaceutical industry wars, Liza M. Walsh formed Walsh to meet client needs for special skills, responsiveness and flexibility. Read Full Article ›...
New Jersey Law Journal placed the founding of Walsh in context with other changes in the legal industry. Read Full Article ›...
Founded in 1979 the US-Asia Institute is a private United Nations-associated NGO devoted to improving understanding and strengthening ties between the people and governments of the United States and Asia. Liza M. Walsh was named the Institute’s newest board member. Read Full Article ›...
A New Jersey federal judge, on May 11, 2016, dismissed a proposed class action alleging Sanofi-Aventis US Inc. encouraged medical providers to bill for free drug samples and engaged in a kickback scheme to persuade retailers to sell its medication, but said it can be refiled...